SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Total revenue for the quarter ended September 2021 of  Rs. 670.03 millions remain, more or less, the same.Handsome Net Profit growth of 99.93% reported above the corresponding previous quarter figure of Rs. 30.55 millions to Rs. 15.28 millions.Operating profit for the quarter ended September 2021 decreased to 73.17 millions as compared to 78.02 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202003 201903 % Var
Sales 670.03 642.76 4.24 3166.38 2870.02 10.33 1706.73 2230.79 -23.49
Other Income 9.11 3.93 131.81 29.57 44.89 -34.13 36.15 27.46 31.65
PBIDT 73.17 78.02 -6.22 358.21 238.80 50.00 98.74 230.54 -57.17
Interest 25.77 31.66 -18.60 143.83 183.64 -21.68 124.16 125.29 -0.90
PBDT 47.40 46.36 2.24 214.38 55.16 288.65 -25.42 105.25 -124.15
Depreciation 17.15 18.01 -4.78 83.39 103.21 -19.20 70.27 61.15 14.91
PBT 30.25 28.35 6.70 130.99 -48.05 -372.61 -95.69 44.10 -316.98
TAX -0.30 13.07 -102.30 31.78 15.57 104.11 -0.41 -23.49 -98.25
Deferred Tax 0.00 0.00 0.00 -2.48 0.00 0.00 0.00 0.00 0.00
PAT 30.55 15.28 99.93 99.21 -63.62 -255.94 -95.28 67.59 -240.97
Equity 148.22 141.72 4.59 148.22 141.72 4.59 141.72 141.72 0.00
PBIDTM(%) 10.92 12.14 -10.03 11.31 8.32 35.96 5.79 10.33 -44.02

Bal Pharma Share Price

77.01 -1.46 (-1.86%)
21-Apr-2026 12:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.20
Dr. Reddys Lab 1219.55
Cipla 1231.55
Zydus Lifesciences 928.40
Lupin 2322.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×